Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.

Company growth
Type
Private
HQ
Utrecht, NL
Founded
2003
Size (employees)
54 (est)+2%
Merus was founded in 2003 and is headquartered in Utrecht, NL

Merus Office Locations

Merus has office in Utrecht
Utrecht, NL

Merus Metrics

Merus Summary

We estimate that Merus's latest funding round in April 2015 was $79.1 M. In total, Merus has raised $149 M
We estimate that Merus's current employees are approximately 30% female and 70% male.

Merus News

Merus Company Life